Titre : Mort par excès de travail

Mort par excès de travail : Questions médicales fréquentes

Termes MeSH sélectionnés :

Case-Control Studies
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mort par excès de travail : Questions médicales les plus fréquentes", "headline": "Mort par excès de travail : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mort par excès de travail : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-14", "dateModified": "2025-05-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mort par excès de travail" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mort subite cardiaque", "url": "https://questionsmedicales.fr/mesh/D016757", "about": { "@type": "MedicalCondition", "name": "Mort subite cardiaque", "code": { "@type": "MedicalCode", "code": "D016757", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.260.322.250" } } }, "about": { "@type": "MedicalCondition", "name": "Mort par excès de travail", "alternateName": "Karoshi Death", "code": { "@type": "MedicalCode", "code": "D065907", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ariane Lewis", "url": "https://questionsmedicales.fr/author/Ariane%20Lewis", "affiliation": { "@type": "Organization", "name": "NYU Langone Medical Center, New York, New York." } }, { "@type": "Person", "name": "David M Greer", "url": "https://questionsmedicales.fr/author/David%20M%20Greer", "affiliation": { "@type": "Organization", "name": "Boston University School of Medicine, Boston, Massachusetts." } }, { "@type": "Person", "name": "Gene Sung", "url": "https://questionsmedicales.fr/author/Gene%20Sung", "affiliation": { "@type": "Organization", "name": "University of Southern California, Los Angeles." } }, { "@type": "Person", "name": "Ning Xiao", "url": "https://questionsmedicales.fr/author/Ning%20Xiao", "affiliation": { "@type": "Organization", "name": "School of Forensic Medicine, Southern Medical University, Guangzhou, Guangdong, China (mainland)." } }, { "@type": "Person", "name": "Yan-Geng Yu", "url": "https://questionsmedicales.fr/author/Yan-Geng%20Yu", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Forensic Pathology, Ministry of Public Security, Guangzhou, Guangdong, China (mainland)." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A case-control study on immunologic markers of patients with vitiligo.", "datePublished": "2022-10-14", "url": "https://questionsmedicales.fr/article/36244264", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.biopha.2022.113785" } }, { "@type": "ScholarlyArticle", "name": "Case-Control Study of Long COVID, Sapporo, Japan.", "datePublished": "2023-04-12", "url": "https://questionsmedicales.fr/article/37044126", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3201/eid2905.221349" } }, { "@type": "ScholarlyArticle", "name": "Endothelium-biomarkers for postthrombotic syndrome: a case-control study.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37016998", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MBC.0000000000001192" } }, { "@type": "ScholarlyArticle", "name": "Risk Factors for Postoperative Pneumonia: A Case-Control Study.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35875004", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.913897" } }, { "@type": "ScholarlyArticle", "name": "Significance of temperature in antimuscarinic toxicity: a case-control study.", "datePublished": "2022-06-23", "url": "https://questionsmedicales.fr/article/35735006", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15563650.2022.2088378" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Mort", "item": "https://questionsmedicales.fr/mesh/D003643" }, { "@type": "ListItem", "position": 5, "name": "Mort subite", "item": "https://questionsmedicales.fr/mesh/D003645" }, { "@type": "ListItem", "position": 6, "name": "Mort subite cardiaque", "item": "https://questionsmedicales.fr/mesh/D016757" }, { "@type": "ListItem", "position": 7, "name": "Mort par excès de travail", "item": "https://questionsmedicales.fr/mesh/D065907" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mort par excès de travail - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mort par excès de travail", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mort par excès de travail", "description": "Comment diagnostiquer le Karoshi ?\nQuels examens sont nécessaires ?\nQuels signes indiquent un risque de Karoshi ?\nLe Karoshi est-il reconnu médicalement ?\nComment évaluer le stress au travail ?", "url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Case-Control+Studies&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mort par excès de travail", "description": "Quels sont les symptômes du Karoshi ?\nLe Karoshi cause-t-il des problèmes cardiaques ?\nY a-t-il des symptômes psychologiques ?\nComment le stress affecte-t-il le corps ?\nLes symptômes varient-ils selon les individus ?", "url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Case-Control+Studies&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mort par excès de travail", "description": "Comment prévenir le Karoshi ?\nLe temps de repos est-il important ?\nLes entreprises peuvent-elles aider ?\nDes programmes de bien-être existent-ils ?\nL'éducation sur le stress est-elle utile ?", "url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Case-Control+Studies&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mort par excès de travail", "description": "Quels traitements sont disponibles pour le Karoshi ?\nLa médication est-elle nécessaire ?\nComment la thérapie aide-t-elle ?\nLes changements de mode de vie sont-ils efficaces ?\nLe soutien social joue-t-il un rôle ?", "url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Case-Control+Studies&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mort par excès de travail", "description": "Quelles complications peuvent survenir ?\nLe Karoshi peut-il entraîner des incapacités ?\nY a-t-il des effets à long terme ?\nLe Karoshi affecte-t-il la qualité de vie ?\nLes complications sont-elles réversibles ?", "url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Case-Control+Studies&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mort par excès de travail", "description": "Quels sont les principaux facteurs de risque ?\nLe manque de soutien social est-il un risque ?\nLes exigences professionnelles influencent-elles ?\nLe type de travail joue-t-il un rôle ?\nL'âge est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D065907?mesh_terms=Case-Control+Studies&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer le Karoshi ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique de travail, les symptômes et l'exclusion d'autres causes." } }, { "@type": "Question", "name": "Quels examens sont nécessaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens médicaux comme des analyses sanguines et des tests cardiaques peuvent être effectués." } }, { "@type": "Question", "name": "Quels signes indiquent un risque de Karoshi ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue extrême, troubles du sommeil, et symptômes cardiovasculaires sont des indicateurs." } }, { "@type": "Question", "name": "Le Karoshi est-il reconnu médicalement ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est reconnu comme une cause de décès liée au travail dans certains pays." } }, { "@type": "Question", "name": "Comment évaluer le stress au travail ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des questionnaires et des évaluations psychologiques peuvent aider à mesurer le stress." } }, { "@type": "Question", "name": "Quels sont les symptômes du Karoshi ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, douleurs thoraciques, et troubles mentaux comme l'anxiété." } }, { "@type": "Question", "name": "Le Karoshi cause-t-il des problèmes cardiaques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut entraîner des maladies cardiaques et des AVC." } }, { "@type": "Question", "name": "Y a-t-il des symptômes psychologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, dépression, irritabilité et troubles de la concentration sont fréquents." } }, { "@type": "Question", "name": "Comment le stress affecte-t-il le corps ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Le stress prolongé peut provoquer des troubles métaboliques et des douleurs physiques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les individus ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de la résilience individuelle et des facteurs de stress." } }, { "@type": "Question", "name": "Comment prévenir le Karoshi ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Équilibrer le travail et la vie personnelle, et gérer le stress sont essentiels." } }, { "@type": "Question", "name": "Le temps de repos est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, prendre des pauses régulières et des congés est crucial pour la santé mentale." } }, { "@type": "Question", "name": "Les entreprises peuvent-elles aider ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en promouvant un environnement de travail sain et en limitant les heures supplémentaires." } }, { "@type": "Question", "name": "Des programmes de bien-être existent-ils ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, de nombreuses entreprises offrent des programmes de bien-être pour leurs employés." } }, { "@type": "Question", "name": "L'éducation sur le stress est-elle utile ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, sensibiliser les employés aux risques du stress peut aider à prévenir le Karoshi." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le Karoshi ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut la thérapie, la gestion du stress et des changements de mode de vie." } }, { "@type": "Question", "name": "La médication est-elle nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Parfois, des antidépresseurs ou anxiolytiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment la thérapie aide-t-elle ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie aide à gérer le stress, à améliorer la santé mentale et à développer des stratégies d'adaptation." } }, { "@type": "Question", "name": "Les changements de mode de vie sont-ils efficaces ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, adopter un mode de vie équilibré, avec du repos et de l'exercice, est crucial." } }, { "@type": "Question", "name": "Le soutien social joue-t-il un rôle ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le soutien des amis et de la famille est essentiel pour la récupération." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des maladies cardiovasculaires, des troubles mentaux et des AVC." } }, { "@type": "Question", "name": "Le Karoshi peut-il entraîner des incapacités ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes de santé chroniques peuvent entraîner des incapacités à long terme." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut avoir des effets durables sur la santé physique et mentale." } }, { "@type": "Question", "name": "Le Karoshi affecte-t-il la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut réduire significativement la qualité de vie et le bien-être général." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié et des changements de mode de vie." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les heures de travail excessives, le stress élevé et un mode de vie sédentaire sont des facteurs clés." } }, { "@type": "Question", "name": "Le manque de soutien social est-il un risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'isolement social peut augmenter le risque de Karoshi et de problèmes de santé." } }, { "@type": "Question", "name": "Les exigences professionnelles influencent-elles ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des exigences professionnelles élevées et des délais serrés augmentent le stress." } }, { "@type": "Question", "name": "Le type de travail joue-t-il un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les emplois à haute pression, comme ceux dans la finance, sont plus à risque." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs plus âgés peuvent être plus vulnérables aux effets du stress au travail." } } ] } ] }

Sources (10000 au total)

Endothelium-biomarkers for postthrombotic syndrome: a case-control study.

The postthrombotic syndrome (PTS) is a long-term complication of deep venous thrombosis (DVT). Increase knowledge on the PTS pathophysiology and novel biomarkers are needed in order to predict PTS dev... A case-control study was conducted. Inclusion criteria were symptomatic and confirmed DVT patients treated with anticoagulants for at least 3 months. Villalta score was performed at the time of inclus... Thirty two patients and 61 controls were included. PTS patients showed higher levels of CEC (0.56/μl (0.34-1.5) vs. 0.20/μl (0.11-0.77); P = 0.04) and EPC (0.75/μl (0.38-1.52) vs. 0.09/μl (0.05-0.82);... The formation and early resolution of DVT are characterized by inflammation and endothelial/platelet activation. We have identified possible novel biomarkers such as CEC, EPC and fractalkine for the d...

Risk Factors for Postoperative Pneumonia: A Case-Control Study.

Postoperative pneumonia is a preventable complication associated with adverse outcomes, that greatly aggravates the medical expenses of patients. The goal of our study is to identify risk factors and ... A matched 1:1 case-control study, including adult patients who underwent surgery between January 2020 and June 2020, was conducted in the Second Affiliated Hospital of Kunming Medical University in Ch... Out of 17,190 surgical patients, 264 (1.54%) experienced postoperative pneumonia. Increased age, chronic obstructive pulmonary disease, emergency surgery, postoperative reduced albumin, prolonged vent... Postoperative pneumonia is associated with severe clinical outcomes. We identified six independent risk factors that can aid in risk stratification and management of patients at risk of postoperative ... www.chictr.org.cn, identifier: chiCTR2100045986....

Significance of temperature in antimuscarinic toxicity: a case-control study.

Antimuscarinic toxicity can result in temperature dysregulation, but the clinical significance of this is unclear. The objective of this study was to compare peak temperatures between antimuscarinic p... This was a case-control analysis at two large, urban, academic medical centers from January 1, 2016, through December 31, 2021. We compared peak temperature (... Fifty-six patients met inclusion criteria of which 23 developed severe outcomes: 16 seizures, 9 cases with hypotension, 5 intubations, and 2 ventricular dysrhythmias. Tmax amongst all patients ranged ... Maximum temperatures did not differ between patients with and without severe outcomes in the setting of antimuscarinic toxicity, and temperature was poorly predictive of outcomes. Our findings suggest...

A postmortem case control study of asbestos burden in lungs of malignant mesothelioma cases.

Asbestos lung content is regarded as the most reliable tool for causal attribution of malignant mesothelioma (MM) to previous asbestos exposures. However, there is a lack of studies on asbestos burden... Asbestos lung content has been assessed on formalin-fixed lung fragments using scanning electron microscopy coupled with energy dispersion spectroscopy (SEM-EDS) on individuals deceased from MM (cases... Asbestos and asbestos bodies (ABs) were found, respectively, in 73.7% and 43.2% of cases and in 28 and 22% of controls; in MM cases the most represented asbestos types were crocidolite and amosite, wh... The results suggest a correlation between asbestos burden in lungs and MM risk. The different concentration of chrysotile, as well as the different width of asbestos fibers in MM males and females mig...

Anemia and Idiopathic Intracranial Hypertension: A Case-Control Study.

Idiopathic intracranial hypertension (IIH) is a condition that mostly affects obese women of childbearing age but has been reported to be temporally related to new diagnoses of anemia. Despite these r... Consecutive IIH patients were recruited from neuro-ophthalmology clinics and matched by age and sex to consecutive patients attending neuro-ophthalmology clinics with diagnoses other than IIH. Complet... One hundred twenty-three IIH patients and 113 controls were included in the study. More IIH patients than controls had anemia (22.8%, 28/123 vs 10.6%, 12/113, P = 0.01) with an odds ratio of 2.48 (95%... Idiopathic intracranial hypertension patients have a higher prevalence of anemia compared with non-IIH neuro-ophthalmology patients. The anemia was mostly mild and may be explained by other factors re...

Study on the association between adverse drug reactions to opioids and gene polymorphisms: a case-case-control study.

Adverse drug reactions (ADRs) caused by opioid drugs show individual differences. Our objective was to explore the association between gene polymorphism and ADRs induced by opioid drugs.... Evidence-based medical data analysis was conducted for genes related to ADRs induced by opioid drugs to select target genes. Sixty patients with cancer pain who had ADRs after taking opioid drugs (mor... Based on a database search and evidence-based medical data, we identified CYP2D6*10, CYP3A5*3, ABCB1, and OPRM1 as target genes for detection. The results of statistical analysis showed no significant... Polymorphism of ABCB1 (062rs1045642) is related to ADRs caused by oxycodone, and the incidence of ADRs is higher with the allele T. Polymorphism of ABCB1 is expected to become a clinical predictor of ...

Systemic hormone therapy and dementia: A nested case-control and co-twin control study.

The effect of systemic hormone therapy (HT) on dementia risk is unclear. Our aim was to investigate the association between HT and dementia.... This register-based study consists of a nested case-control study and a co-twin control design, which controls for familial confounding, including shared genetics.... Through Danish national registries from 1995 to 2011, we identified: a) 2700 female singletons with incident dementia and 13,492 matched controls; b) 288 female twins with incident dementia and co-twi... The odds ratio (OR) for the association between systemic HT and dementia was 1.05, 95% CI = [0.93-1.19] in singletons and 2.10, 95% CI = [0.99-4.46] in twins. A statistically significant association w... Using Danish nationwide registries and controlling for education and for familial factors in a subsample, systemic HT was found to be associated with increased dementia risk if used before 2003, when ...